Subject
Medicine (miscellaneous),Health Policy,Education
Reference6 articles.
1. European Medicines Agency. European Medicines Agency Benefit-Risk methodology project. Description of the current practice of benefit-risk assessment for centralised procedure products in the EU regulatory network. EMA/213482/2010, 30 March 2010. http://www.ema.europa.eu/docs/en_GB/document_library/Report/2010/04/WC500089603.pdf
2. Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials;Eyding;BMJ,2010
3. Finding studies on reboxetine: a tale of hide and seek;Wieseler;BMJ.,2010
4. Reporting bias in medical research - a narrative review;McGauran;Trials.,2010
5. Falsche Gelassenheit;Lelgemann;Z Evid Fortbild Qual Gesundhwes,2010